While most individuals impacted by COVID-19 experience milder symptoms and recover within a few weeks, the global pandemic caused by the SARS-CoV-2 virus continues to pose a significant health ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge Blockchain announced a new partnership with Zensark today. The partnership enables Cambridge Blockchain’s Tracelinks to offer an AI-powered cough analyzer ...

Please provide your email address to receive an email when new articles are posted on . Gefapixant 45 mg twice daily resulted in clinically important reductions in cough frequency compared with ...

Imagine if you could accurately identify COVID-19 in an individual with the help of a smartphone app that only needs to listen to the person’s cough. Researchers at the University of Essex have ...

While most individuals impacted by COVID-19 experience milder symptoms and recover within a few weeks, the global pandemic caused by the SARS-CoV-2 virus continues to pose a significant health ...

Artificial intelligence is steadily reshaping healthcare, and one of its most promising applications is emerging in respiratory disease screening. Researchers and healthcare startups are increasingly ...

Researchers at MIT have used machine learning to create software capable of detecting whether a person has caught COVID-19 by analyzing their cough, a development that could eventually result in an ...

A meta-analysis of published literature confirmed that N-aceteylcysteine, a cough medication, was effective at improving symptoms and lung function of patients with acute exacerbation of chronic ...